Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis

Current Cardiovascular Risk Reports(2021)10.1007/s12170-021-00670-ySource: DataRank Database

Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis is a research paper published in Current Cardiovascular Risk Reports (2021). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (9)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Joyce Njoroge ORCID,Keon Pearson ORCID,Ronald Witteles ORCID,MANDAR A. ARAS,Kevin Alexander ORCID

Live enrichment

PubMed:35280930 PMC:PMC8916707

American Heart Association

Grant: 19AMFDP34990036

National Institutes of Health

Grant: KL2TR003143

NIA NIH HHS

Grant: P30 AG059307

National Institutes of Health

Grant: 5KL2TR003143-04

Institutional Career Development Core (KL2)

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8916707

publisherhttps://link.springer.com/content/pdf/10.1007/s12170-021-00670-y.pdf

publisherhttps://link.springer.com/article/10.1007/s12170-021-00670-y/fulltext.html

https://doi.org/10.1007/s12170-021-00670-y

https://pubmed.ncbi.nlm.nih.gov/35280930

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

AmyloidosisDiagnosisTreatmentCardiomyopathyRacial DisparitiestransthyretinCardiac Scintigraphy

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (6)

Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms

N/A

8.2DataRank · unranked

Nature Communications(2021)

co-cited

10.1038/s41467-021-22877-8

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

N/A

0.713DataRank · unranked

Nature Communications(2021)

co-cited

10.1038/s41467-021-22876-9

Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction

Top 41%

0.456DataRank

European Heart Journal Acute Cardiovascular Care(2022)

co-cited

10.1093/ehjacc/zuac075

Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study

N/A

1.3DataRank · unranked

Journal of the American Heart Association(2023)

co-cited

10.1161/jaha.122.028973

Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool

Top 18%

1.1DataRank

European Heart Journal(2025)

co-cited

10.1093/eurheartj/ehaf387

Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy

European Heart Journal(2025)

co-cited

10.1093/eurheartj/ehaf450